LivaNova (LIVN) Retained Earnings (2015 - 2026)
LivaNova (LIVN) reported Retained Earnings of -$1.1 billion for Q1 2026, down 2529.25% on a YoY basis from $46.2 million in Q1 2025, and up 1.95% sequentially from -$1.1 billion in Q4 2025.
LivaNova (LIVN) Retained Earnings (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Retained Earnings data on file, last reported at -$1.1 billion in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 2529.25% year-over-year to -$1.1 billion; the trailing twelve-month figure through Mar 2026 stood at -$1.1 billion (down 2529.25% YoY), and the FY2025 full-year result was -$1.1 billion, down 1329.11% from the prior year.
- Retained Earnings grew to -$1.1 billion in Q1 2026, from -$1.1 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $8.1 million in Q2 2025 to a low of -$1.2 billion in Q3 2025.
- A 5-year average of -$613.7 million and a median of -$894.8 million in 2022 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings plunged 3906.49% in 2022 and soared 115.36% in 2025, its largest moves.
- Tracing LIVN's Retained Earnings over 5 years: stood at -$48.1 million in 2022, then sank by 1908.53% to -$966.5 million in 2023, then jumped by 91.7% to -$80.2 million in 2024, then slumped by 1329.11% to -$1.1 billion in 2025, then increased by 1.95% to -$1.1 billion in 2026.
- Business Quant data shows LIVN's Retained Earnings at -$1.1 billion in Q1 2026, -$1.1 billion in Q4 2025, and -$1.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.32 Bn |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn | -1.12 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.12 Bn |
| Dec 31, 2025 | -1.15 Bn |
| Sep 30, 2025 | -1.18 Bn |
| Jun 30, 2025 | 8.11 Mn |
| Mar 31, 2025 | -42.73 Mn |
| Dec 31, 2024 | -80.17 Mn |
| Sep 30, 2024 | -959.14 Mn |
| Jun 30, 2024 | -52.82 Mn |
| Mar 31, 2024 | -45.21 Mn |
| Dec 31, 2023 | -966.48 Mn |
| Sep 30, 2023 | -982.82 Mn |
| Jun 30, 2023 | -975.51 Mn |
| Mar 31, 2023 | -976.66 Mn |
| Dec 31, 2022 | -48.12 Mn |
| Sep 30, 2022 | -93.10 Mn |
| Jun 30, 2022 | -878.35 Mn |
| Mar 31, 2022 | -894.79 Mn |
| Dec 31, 2021 | -897.78 Mn |
| Sep 30, 2021 | -879.66 Mn |
| Jun 30, 2021 | 23.08 Mn |